Appointments

216.444.KIDS (5437)

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Doctor Profile

Firas Saker, MD

216.444.2568

Firas Saker, MD

Appointed: 2009

Firas Saker, MD
Department: Neonatology
Location: Cleveland Clinic Main Campus
Mail Code M31
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2568
WorkFax:440.312.8431
Firas Saker, MD
Department: Neonatology
Location: Hillcrest Hospital
Mail Code M31
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:216.444.2568
WorkFax:440.312.8431
Surgeon:
No
Treats:
Children & Adolescents Only

Biographical Sketch

Firas Saker, M.D., holds multiple appointments with Cleveland Clinic Children’s Hospital. He is the associate Chair for the Department of Neonatology at Cleveland Clinic Foundation, he also is the medical director of the Neonatal Intensive Care Unit at Hillcrest Hospital. In addition, Dr. Saker is a Clinical Associate Professor of Pediatrics at Cleveland Clinic Learner College of Medicine of Case Western Reserve University.

Dr. Saker is double board certified in both pediatrics and neonatal/perinatal medicine. He earned his medical degree from Damascus University School of Medicine in Damascus, Syria. His post-graduate training includes a pediatric residency at Texas Tech University School of Medicine in El Paso, Texas, and a neonatal/perinatal fellowship at Case Western Reserve University and Rainbow Babies & Children's Hospital in Cleveland, Ohio.

In addition to his clinical practice, Dr. Saker is a member of several professional organizations, including the American Academy of Pediatrics, Section of Perinatal Medicine. He also serves on several committees for Cleveland Clinic Health Care System, including the Reproductive Ethics Subcommittee, NICU Design Committee, and Infection Disease Control Committee at Hillcrest Medical Center; as well as the Blood Conservation Committee at Main Campus, among others.
 
Dr. Saker has received a number of awards and recognitions. Most recently he was selected by his colleagues to be included in the Best Doctor's list in America for the year 2011-2012. He also received a Lifetime Service Award from the Syrian American Medical Society.
 
An established clinical researcher, Dr. Saker has secured a number of grants for his work and has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings.

 

Education & Fellowships

Fellowship - University Hospitals of Cleveland
Neonatology
Cleveland, OH USA
1996
Residency - Texas Tech University Health Science Center-El-Paso
Pediatrics
El-Paso, TX USA
1991
Internship - Meharry Medical College
Pediatrics
Nashville, TN USA
1989
Medical School - Damascus University-Faculty of Medicine
Damascus Syria
1986

Certifications

  • Pediatrics
  • Pediatrics- Neonatal-Perinatal Medicine

Specialty Interests

1-Neonatal Metabolism & Nutrition. 2-Respiratory distress syndrome in newborn

Treatment & Services

  • Nutrition Sciences

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/6/2014, Dr. Saker has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • Arabic
  • English